Diagnostics News and Research

RSS

Sherpa opens new CGMP production facility in San Diego

Sherpa Clinical Packaging, a privately held provider of Clinical Trial Material management services, hosted a ribbon cutting ceremony today to mark the opening of its newly constructed state-of-the-art, CGMP production facility in San Diego, CA.

19 Jul 2011

Preliminary data from Amorfix human diagnostic test for Alzheimer's presented at ICAD

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, presented a paper on Sunday July 17th, 2011 at the International Conference on Alzheimer's disease in Paris, France.

19 Jul 2011

Roche signs agreement to acquire mtm laboratories

Ventana Medical Systems, Inc., a member of the Roche Group, announced today that Roche has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany.

From Roche Sequencing and Life Science 19 Jul 2011

U.S. FDA approves 2011-2012 influenza vaccine formulation

The U.S. Food and Drug Administration announced today that it has approved the influenza vaccine formulation for the 2011-2012 vaccine that will be used by the six manufacturers licensed to produce and distribute influenza vaccine for the United States.

19 Jul 2011

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.

18 Jul 2011

Panel discussion on global perspective of women and Alzheimer's held at AAIC 2011

Today the Alzheimer's Association® in conjunction with GE Healthcare held a "Women and Alzheimer's: A Global Perspective" panel discussion during the Alzheimer's Association International Conference 2011 (AAIC). The event brought together leaders in the Alzheimer's field and revealed new data from a survey commissioned by Alzheimer Europe.

18 Jul 2011

European Commission Framework 7 programme awards €3 million grant to Enigma Diagnostics

In October 2007, Enigma Diagnostics announced the award of a euro 3 Million grant by the European Commission Framework 7 programme. This EU Commission award was won in a competitive process and the grant was to support development of a rapid, fully automated molecular diagnostic system for Seasonal Influenza (circulating strains of Influenza types A & B) to be based on Enigma's concept ML instrument system.

18 Jul 2011

Study sheds light on the way antibodies distinguish between different 'biomarkers'

A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' - proteins which reveal information about the condition of the human body.

15 Jul 2011

State roundup: Model insurance brings 'modest' savings

Blue Cross Blue Shield of Massachusetts' alternative quality contract, which Governor Deval Patrick has held up as a potential model for controlling health care costs, produced "modest" savings in its first year while yielding improved quality of care in some areas, according to a new study in this week's New England Journal of Medicine.

15 Jul 2011

Non-invasive 'swine flu' breath test could help ease future vaccine shortages

A test, novel breath measuring the immune response to the H1N1 flu virus, could help to ease future vaccine shortages by identifying the people who have already been infected with the flu virus.

15 Jul 2011

Cancer may soon affect 40% of UK’s population: Report

Macmillan Cancer Support this Thursday revealed warning estimates that four in 10 people in the UK will get cancer at some point in their lives, up from one in three a decade ago. Cancer experts now believe 42% of Britons will get the disease.

14 Jul 2011

FDA issues draft guidance to promote development of targeted medicines, diagnostics

The U.S. Food and Drug Administration today issued a new draft guidance to facilitate the development and review of companion diagnostics – tests used to help health care professionals determine whether a patient with a particular disease or condition should receive a particular drug therapy or how much of the drug to give.

13 Jul 2011

Illumina announces availability of new TruSeq Custom Enrichment kits

Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.

From Illumina, Inc. 13 Jul 2011

Source BioScience receives NHS approval for automated cervical cancer screening technology

Source BioScience (LSE: SBS), the international diagnostics and genetic analysis business, is pleased to announce that the National Health Service Cancer Screening Programmes (“NHSCSP”) has approved the use of the BD FocalPoint “No Further Review” technology for cervical cancer screening in the UK. This is the only automated cervical screening technology which has been approved.

13 Jul 2011

Enrollment commences in Exact Sciences' colorectal cancer screening trial

Exact Sciences today announced the initiation of the pivotal trial for the company's multi-marker molecular diagnostic screening test for the early detection of colorectal cancer.

13 Jul 2011

Affymetrix commences shipment of gene profiling reagents

Affymetrix, Inc. today began shipping its FDA-cleared Gene Profiling Reagents. Affymetrix also announced the availability of the new Gene Profiling Array cGMP U133 P2, a version of the widely cited Human Genome U133 Plus 2.0 Array, as another component to its GeneChip Instrument System, which is used by Affymetrix partners for assay development.

12 Jul 2011

Cancer Cell publishes results of melanoma study

Metamark Genetics, Inc., a privately-held oncology-focused molecular diagnostics company, today announced results from a melanoma study published in Cancer Cell.

12 Jul 2011

Endosense completes first patient case utilizing new prototype software

Endosense, a Swiss medical technology company, has announced completion of the first patient case utilizing prototype software that integrates the contact-force data provided by Endosense's TactiCath force-sensing ablation catheter with Siemens Healthcare's electrophysiology solutions.

11 Jul 2011

Illumina, Sequenom sign three-year supply agreement

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced it has signed a three-year supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools for the large-scale analysis of genetic variation and function.

From Illumina, Inc. 11 Jul 2011

Randox launches Lab Tests Blog

Randox Laboratories is excited to announce the launch of its very own online blog - Lab Tests Blog.

From Randox Laboratories Ltd. 11 Jul 2011

Diagnostics News and Research

Sherpa opens new CGMP production facility in San Diego

Preliminary data from Amorfix human diagnostic test for Alzheimer's presented at ICAD

Roche signs agreement to acquire mtm laboratories

U.S. FDA approves 2011-2012 influenza vaccine formulation

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

Panel discussion on global perspective of women and Alzheimer's held at AAIC 2011

European Commission Framework 7 programme awards €3 million grant to Enigma Diagnostics

Study sheds light on the way antibodies distinguish between different 'biomarkers'

State roundup: Model insurance brings 'modest' savings

Non-invasive 'swine flu' breath test could help ease future vaccine shortages

Cancer may soon affect 40% of UK’s population: Report

FDA issues draft guidance to promote development of targeted medicines, diagnostics

Illumina announces availability of new TruSeq Custom Enrichment kits

Source BioScience receives NHS approval for automated cervical cancer screening technology

Enrollment commences in Exact Sciences' colorectal cancer screening trial

Affymetrix commences shipment of gene profiling reagents

Cancer Cell publishes results of melanoma study

Endosense completes first patient case utilizing new prototype software

Illumina, Sequenom sign three-year supply agreement

Randox launches Lab Tests Blog

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News